Among others, the anti-tumor effects of CXCL10 and CXCL9 have been shown to be mediated through the recruitment of activated CD4 and CD8 T cells37 as well as through their inhibitory effects on tumor vasculature38. This evidence concerns the gene CD8A and neoplasm.